Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTMO
āļāļ·āđāļāļāļĢāļīāļĐāļąāļThermo Fisher Scientific Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 27, 1980
āļāļĩāļāļĩāđāļCasper (Marc N)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ125000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 27
āļāļĩāđāļāļĒāļđāđ168 Third Avenue
āđāļĄāļ·āļāļWALTHAM
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ02451
āđāļāļĢāļĻāļąāļāļāđ17816221000
āđāļ§āđāļāđāļāļāđhttps://corporate.thermofisher.com/us/en/index.html
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTMO
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 27, 1980
āļāļĩāļāļĩāđāļCasper (Marc N)
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Mr. Michael D. Shafer
Executive Vice President
Mr. Nelson J. Chai
Independent Director
Mr. Gianluca Pettiti
Executive Vice President
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Mr. Michael D. Shafer
Executive Vice President
Mr. Nelson J. Chai
Independent Director
VanEck Morningstar Wide Moat Value ETF
Goldman Sachs Future Health Care Equity ETF
Parnassus Value Select ETF
Health Care Select Sector SPDR Fund
Proshares Ultra Health Care
iShares U.S. Healthcare ETF
AdvisorShares Focused Equity ETF
Brookstone Value Stock ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļāļŠāđāļ§āļ5.72%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļāļŠāđāļ§āļ5.09%
Honeytree US Equity ETF
āļŠāļąāļāļŠāđāļ§āļ4.9%
Parnassus Value Select ETF
āļŠāļąāļāļŠāđāļ§āļ4.52%
Health Care Select Sector SPDR Fund
āļŠāļąāļāļŠāđāļ§āļ4.39%
Proshares Ultra Health Care
āļŠāļąāļāļŠāđāļ§āļ4.24%
iShares U.S. Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ4.2%
AdvisorShares Focused Equity ETF
āļŠāļąāļāļŠāđāļ§āļ4.01%
Brookstone Value Stock ETF
āļŠāļąāļāļŠāđāļ§āļ3.97%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
2.29B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
TMO.NB Final Cash Dividend of gross USD 0.43 paid on Oct 15, 2025 going ex on Sep 15, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Jul 15, 2025 going ex on Jun 13, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ